Adia Nutrition Officially Enters $15.1 Billion Global Stem Cell Market with Domestic Treatments by Successful Opening of First Florida Location
"With the global stem cell market expanding, we see an opportunity to make these treatments more accessible in the U.S.," ...
Adia Nutrition Advances Towards OTCQB Uplisting with Third-Party Audit and Provides Roadmap to Listing on Nasdaq Small Cap
Adia Nutrition's diverse portfolio, including its groundbreaking work in stem cell therapy through Adia Med, has positioned the company as a pioneer in the health sector. The anticipated uplisting is ...